Exploring the views of medical practitioners on proposed legislative changes in Western Australia to support supervised pharmacist prescribing in the hospital setting

IF 1 Q4 PHARMACOLOGY & PHARMACY
Rachel Thorson BPharm, PGDipClinPharm, Barry Jenkins BPharm
{"title":"Exploring the views of medical practitioners on proposed legislative changes in Western Australia to support supervised pharmacist prescribing in the hospital setting","authors":"Rachel Thorson BPharm, PGDipClinPharm,&nbsp;Barry Jenkins BPharm","doi":"10.1002/jppr.70026","DOIUrl":null,"url":null,"abstract":"<p>Supervised pharmacist prescribing (SPP) in the hospital setting, also known as Partnered Pharmacist Medication Prescribing (PPMP), represents a collaborative model of non-medical prescribing which could enable additional gains in efficiency, safety, and increased health service capacity. Following successful implementation of Partnered Pharmacist Medication Charting (PPMC) within our 783-bed quaternary metropolitan hospital, located in Western Australia, Australia, approximately 1800 medical practitioners were invited to complete a five-question survey via email to ascertain whether implementing SPP would be supported and thought to add value. There were 262 responses received within a two-week period, with 77.8% of doctors indicating they felt SPP would be beneficial to their team/the hospital. The Pharmacy Board of Australia previously concluded pharmacist prescribing within a collaborative healthcare environment fell within the current scope of pharmacist practice and that there were no regulatory barriers under national law. Our proposed model of SPP aligns with the Australian Medical Association's position on non-medical prescribing and recommendations in the Western Australian Sustainable health review. This project was exempt due to the local policy requirements that constitute research by the South Metropolitan Health Service Human Research Ethics Committee and registered as a quality improvement project in WA Health Governance, Evidence, Knowledge, Outcomes (Reference no: GEKO48966). The justification for this exemption was as follows: the project presented minimal patient risk and conforms with the National Health and Medical Research Council's <i>Ethical considerations in quality assistance and evaluation activities</i>. Informed consent was obtained from all participants. Potential participants were given project information via email indicating their participation was voluntary and anonymous. Participants provided their consent by completing the survey.</p>","PeriodicalId":16795,"journal":{"name":"Journal of Pharmacy Practice and Research","volume":"55 5","pages":"436-440"},"PeriodicalIF":1.0000,"publicationDate":"2025-07-17","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://onlinelibrary.wiley.com/doi/epdf/10.1002/jppr.70026","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Journal of Pharmacy Practice and Research","FirstCategoryId":"1085","ListUrlMain":"https://onlinelibrary.wiley.com/doi/10.1002/jppr.70026","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q4","JCRName":"PHARMACOLOGY & PHARMACY","Score":null,"Total":0}
引用次数: 0

Abstract

Supervised pharmacist prescribing (SPP) in the hospital setting, also known as Partnered Pharmacist Medication Prescribing (PPMP), represents a collaborative model of non-medical prescribing which could enable additional gains in efficiency, safety, and increased health service capacity. Following successful implementation of Partnered Pharmacist Medication Charting (PPMC) within our 783-bed quaternary metropolitan hospital, located in Western Australia, Australia, approximately 1800 medical practitioners were invited to complete a five-question survey via email to ascertain whether implementing SPP would be supported and thought to add value. There were 262 responses received within a two-week period, with 77.8% of doctors indicating they felt SPP would be beneficial to their team/the hospital. The Pharmacy Board of Australia previously concluded pharmacist prescribing within a collaborative healthcare environment fell within the current scope of pharmacist practice and that there were no regulatory barriers under national law. Our proposed model of SPP aligns with the Australian Medical Association's position on non-medical prescribing and recommendations in the Western Australian Sustainable health review. This project was exempt due to the local policy requirements that constitute research by the South Metropolitan Health Service Human Research Ethics Committee and registered as a quality improvement project in WA Health Governance, Evidence, Knowledge, Outcomes (Reference no: GEKO48966). The justification for this exemption was as follows: the project presented minimal patient risk and conforms with the National Health and Medical Research Council's Ethical considerations in quality assistance and evaluation activities. Informed consent was obtained from all participants. Potential participants were given project information via email indicating their participation was voluntary and anonymous. Participants provided their consent by completing the survey.

Abstract Image

探索医疗从业者对西澳大利亚州拟议立法改革的看法,以支持在医院设置监督药剂师处方
医院环境中的监督药剂师处方(SPP),也称为合作药剂师药物处方(PPMP),代表了一种非医疗处方的协作模式,可以在效率、安全性和提高卫生服务能力方面获得额外收益。在我们位于澳大利亚西澳大利亚州的拥有783张床位的第四大都市医院成功实施合作药剂师用药图表(PPMC)后,我们邀请了大约1800名医生通过电子邮件完成了一项五个问题的调查,以确定是否支持实施合作药剂师用药图表并认为其增加了价值。在两周内收到了262份回复,77.8%的医生表示他们认为SPP对他们的团队/医院有益。澳大利亚药房委员会以前的结论是,在协作保健环境中药剂师开处方属于药剂师目前的执业范围,根据国家法律不存在监管障碍。我们提出的SPP模式与澳大利亚医学协会关于非医疗处方的立场和西澳大利亚可持续健康审查中的建议一致。由于地方政策要求,该项目是由南都市卫生服务人类研究伦理委员会进行的研究,因此该项目获得豁免,并在西澳大利亚州卫生治理、证据、知识和成果中注册为质量改进项目(参考编号:GEKO48966)。这一豁免的理由如下:该项目对患者的风险最小,符合国家卫生和医学研究委员会在质量援助和评价活动中的道德考虑。获得了所有参与者的知情同意。潜在的参与者通过电子邮件获得项目信息,表明他们的参与是自愿和匿名的。参与者通过完成调查表示同意。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
Journal of Pharmacy Practice and Research
Journal of Pharmacy Practice and Research Health Professions-Pharmacy
CiteScore
1.60
自引率
9.50%
发文量
68
期刊介绍: The purpose of this document is to describe the structure, function and operations of the Journal of Pharmacy Practice and Research, the official journal of the Society of Hospital Pharmacists of Australia (SHPA). It is owned, published by and copyrighted to SHPA. However, the Journal is to some extent unique within SHPA in that it ‘…has complete editorial freedom in terms of content and is not under the direction of the Society or its Council in such matters…’. This statement, originally based on a Role Statement for the Editor-in-Chief 1993, is also based on the definition of ‘editorial independence’ from the World Association of Medical Editors and adopted by the International Committee of Medical Journal Editors.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术官方微信